Technology
Health
Biotechnology

CSL Limited

$69.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-0.50%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CSL Limited and other stocks, options, ETFs, and crypto commission-free!

About

Csl Ltd SPONSORED ADR (Australia), also called CSL Limited, is a biopharmaceutical company, which engages in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. Read More The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia. CSLLY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
22,220
Headquarters
Parkville, Victoria (VIC)
Founded
1961
Market Cap
62.82B
Price-Earnings Ratio
34.93
Dividend Yield
1.05
Average Volume
61.52K
High Today
$69.60
Low Today
$69.08
Open Price
$69.49
Volume
25.55K
52 Week High
$83.12
52 Week Low
$58.65

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Advertising and Marketing
Pharmaceutical
Business Services
2014 IPO
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.